Successful Vaginal Pain Drug Trial Sends TherapeuticsMD Soaring
This article is for subscribers only.
Shares of women’s health drug developer TherapeuticsMD Inc. soared in late trading Monday after the company said its trial of a hormonal treatment to reduce vaginal pain during intercourse was successful.
In a final-stage trial of 764 post-menopausal woman, all three dosage levels of TherapeuticsMD’s estradiol treatment helped reduce pain during intercourse for post-menopausal patients with vulvar and vaginal atrophy, when compared to a placebo, the company said in a statement. Estradiol is a reproductive hormone that helps with the growth and maintenance of reproductive tissues. It also plays a key role during puberty.